Skip to content
healthcare.dev

Menveo

NDC 58160-955, Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, kit, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-955
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
KIT
Route
—
Product type
VACCINE
Marketing category
BLA
Application
BLA125300
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-955 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

None listed.

Package NDCNDC-11Package
58160-955-09581600955091 KIT in 1 CARTON (58160-955-09) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-958-01) * .5 mL in 1 VIAL, SINGLE-DOSE (58160-959-01)

Linked data

RxNorm, label and prices

Use it

Look up 58160-955 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-955 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-955. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.